HomeNewsBusinessInterview | Govt should consider re-opening travel for fully vaccinated people: EaseMyTrip CEO Nishant Pitti

Interview | Govt should consider re-opening travel for fully vaccinated people: EaseMyTrip CEO Nishant Pitti

The government should set up funds, and not just provide guarantees for loans as there is a lot of joblessness in the sector currently, EaseMyTrips’s chief executive officer and co-founder Nishant Pitti told Moneycontrol in an interview.

July 22, 2021 / 15:28 IST
Story continues below Advertisement
EaseMyTrips CEO and co-founder Nishant Pitti
EaseMyTrips CEO and co-founder Nishant Pitti

In a bid to help India’s tourism industry recover from the impact of COVID-19, the government should consider easing travel restrictions for fully vaccinated people, EaseMyTrips’s chief executive officer and co-founder Nishant Pitti told Moneycontrol in an interview.

The government should set up funds, and not just provide guarantees for loans as there is a lot of joblessness in the sector currently, Pitti said.

Story continues below Advertisement

In the past year, his company has worked towards improving its operating margins and commissions, and has also reduced operational expenses, Pitti added. Here are edited excerpts of the interview:

Q. What are the additional steps the government can take to help revive the sector?

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show